Quarterly report pursuant to Section 13 or 15(d)

SHAREHOLDERS' DEFICIT (Details 2)

v3.10.0.1
SHAREHOLDERS' DEFICIT (Details 2)
 6 Months Ended
Jun. 30, 2018
USD ($)
$ / shares
shares
Number of Warrants  
Balance Outstanding, Beginning | shares 14,894,213
Balance Outstanding, Ending | shares 14,494,213
Exercisable, Ending | shares 11,500,822
Weighted Average Exercise Price  
Balance Outstanding, Beginning | $ / shares $ 0.32
Balance Outstanding, Ending | $ / shares 0.32
Exercisable, Ending | $ / shares $ 0.32
Weighted Average Remaining Contractual Term (Years)  
Balance Outstanding, Ending 7 years 1 month 27 days
Exercisable, Ending 6 years 8 months 19 days
Aggregate Intrinsic Value  
Balance Outstanding, Beginning | $ $ 7,948,708
Balance Outstanding, Ending | $ 2,314,323
Exercisable, Ending | $ $ 265,334
Warrants [Member]  
Number of Warrants  
Balance Outstanding, Beginning | shares 0
Granted | shares 293,123
Cancelled | shares (293,123)
Balance Outstanding, Ending | shares 0
Exercisable, Ending | shares 0
Weighted Average Exercise Price  
Balance Outstanding, Beginning | $ / shares $ 0.00
Granted | $ / shares 0.87
Cancelled | $ / shares (0.87)
Balance Outstanding, Ending | $ / shares 0.00
Exercisable, Ending | $ / shares $ 0.00
Aggregate Intrinsic Value  
Balance Outstanding, Beginning | $ $ 0
Balance Outstanding, Ending | $ 0
Exercisable, Ending | $ $ 0